Galecto, Inc. (GLTO)
NASDAQ: GLTO · Real-Time Price · USD
28.69
-0.22 (-0.76%)
At close: Mar 9, 2026, 4:00 PM EDT
28.14
-0.55 (-1.92%)
After-hours: Mar 9, 2026, 5:01 PM EDT
Galecto Employees
Galecto had 5 employees as of December 31, 2024. The number of employees decreased by 8 or -61.54% compared to the previous year.
Employees
5
Change (1Y)
-8
Growth (1Y)
-61.54%
Revenue / Employee
n/a
Profits / Employee
-$3,168,800
Market Cap
1.73B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5 | -8 | -61.54% |
| Dec 31, 2023 | 13 | -32 | -71.11% |
| Dec 31, 2022 | 45 | 5 | 12.50% |
| Dec 31, 2021 | 40 | 12 | 42.86% |
| Dec 31, 2020 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Vericel | 357 |
| Zymeworks | 264 |
| Relay Therapeutics | 192 |
| Olema Pharmaceuticals | 122 |
| Pharvaris | 118 |
| Definium Therapeutics | 106 |
| Enliven Therapeutics | 65 |
GLTO News
- 25 days ago - Galecto Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $316.3 Million - GlobeNewsWire
- 26 days ago - Galecto Announces Pricing of $275 Million Underwritten Public Offering - GlobeNewsWire
- 2 months ago - Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - GLTO, MOVE: two penny stocks quadrupled today – but should you buy? - Invezz
- 4 months ago - Galecto Stock Soars: Strengthens Blood Cancer Pipeline With Damora Therapeutics Deal, Secures Fresh Funding To 2029 - Benzinga
- 4 months ago - Galecto Announces Acquisition of Damora Therapeutics - GlobeNewsWire
- 4 months ago - Galecto Reports Third Quarter 2025 Operating and Financial Results - GlobeNewsWire
- 5 months ago - What's Going On With Nano-Cap Galecto Stock On Tuesday? - Benzinga